Risk factors of stroke in Pakistan: A dedicated stroke clinic experience

Canadian Journal of Neurological Sciences

Volumn 37, Issue 2, 2010, Pages 252-257

  Taj, Fawad ^a   Zahid, Rehan ^a   Syeda, Umm E Rubab ^a   Murtaza, Muhammed ^a   Ahmed, Shahzad ^b   Kamal, Ayeesha Kamran ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; DEVELOPING COUNTRY; DIABETES MELLITUS; DISABILITY; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; EXPERIENCE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL INFORMATICS; MEDICAL RECORD REVIEW; OUTPATIENT DEPARTMENT; PAKISTAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 76649126746     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100010015     Document Type: Article

References (22)

1. Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol. [Reflection and Reaction]. 2007 Feb;6(2):94-97
2. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971 Oct;49(4):509-538
3. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009 Apr;8(4):355-369
4. Truelsen T, Heuschmann P, Bonita R, Arjundas G, Dalal P, Damasceno A, et al. Standard method for developing stroke registers in low-income and middle-income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke). Lancet Neurol. 2007 Feb;6 (2):134-139
5. Moussouttas M, Aguilar L, Fuentes K, Anyanwu B, Manassarians H, Papamitsakis N, et al. Cerebrovascular disease among patients from the Indian subcontinent. Neurology. 2006 Sep 12; 67(5):894-896
6. Feigin VL LC, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. [Review]. 2003 Jan;2(1):43-53.
7. Lin Y, Li YS, Xu Q, Shi GW, Li HW, Geng JL. [The impact of stroke clinic on improving the compliance with the guidelines for secondary prevention of ischemic stroke]. Zhonghua Nei Ke Za Zhi. 2007 Sep;46(9):736-739
8. Mouradian MS, Hussain MS, Lari H, Salam A, Senthilselvan A, Dean N, et al. The impact of a stroke prevention clinic in diagnosing modifiable risk factors for stroke. Can J Neurol Sci. 2005 Nov;32(4):496-500.
9. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988 Dec;19(12):1497-1500
10. Brott T, Adams HP, Jr., Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul;20(7):864-870
11. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957 May;2(5):200-215
12. Wade DT, Collin C. The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud. 1988;10(2):64-67
13. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan; 24(1):35-41.
14. Diagnosis and classification of diabetes mellitus. American Diabetes Association. Diabetes Care. 2006 Jan;29 Suppl 1: S43-8.
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21; 289(19):2560-2572
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486-2497
17. Brown MM, Rudd A, McGovern R. Transient ischemic attack- proposed new definition. N Engl J Med. 2003 Apr 17;348(16): 1607-9; author reply -9.
18. Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart Study. Stroke. 2009 Apr;40 (4)1032-1037
19. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009 Apr;40(4): 1082-1090
20. Jacobs DR, Jr., McGovern PG, Blackburn H. The US decline in stroke mortality: what does ecological analysis tell us? Am J Public Health. 1992 Dec;82(12):1596-1599
21. Lin T, Chen CH, Chou P. Impact of the high-risk and mass strategies on hypertension control and stroke mortality in primary health care. J Hum Hypertens. 2004 Feb;18(2):97-105.
22. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009 May;8(5):453-463